Vecuronium

Non-depolarizing Neuromuscular Blocking Agent

• - Onset: 1-3 minuets
• - Duration: 30-60 minuets
• - Minimal effect on heart rate and blood pressure
• - Causes chemical muscle paralysis for intubation
• - Vecuronium competes with acetylcholine for cholinergic receptor sites on post-junctional neuromuscular membranes
• - A sedative, such as Versed or Etomidate, must be given in conjustion with Vecuronium

To maintain muscular paralysis following successful Rapid Sequence Induction (RSI) Intubation

• - Hypersensitivity
• - Inability to control the airway (non-intubated patient)

• - ONLY use after successful intubation with use of Succinylcholine as initial paralytic
• - Wheezing, aspiration, dysrhythmias, bradycardia, sinus arrest, hypertension, hypotension, increased intracranial pressure

0.1 mg/kg to a max single dose of 10mg - mayr repeat in 30-40 mins as needed - watch for patient movement

10mg / 10mL vials